When most people think of clinical trials, they think of trials that test new drugs and drug combinations. However, clinical trials also study ways to improve...Read More
On January 27, 2023, the FDA approved elacestrant (OrserduTM, Stemline Therapeutics, Inc.) and a companion diagnostic test for the treatment of people with...Read More
At the end of January 2023, the FDA approved a new drug called elacestrant (OrserduTM) for people with estrogen receptor-positive, HER2-negative MBC with an ESR1...Read More
Participating in a clinical trial is a process that involves many steps. Click the links below to learn about what to expect while participating in a clinical...Read More
On January 9th, 2023, our partner, the Dr. Susan Love Foundation for Breast Cancer Research, hosted a clinical trials webinar featuring our very own Susan Colen,...Read More
SEARCH OUR SITE
for past articles or specific information.